Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention (PCI)

NCT03567408 is registered in ClinicalTrials.gov with Qian Gong as lead sponsor.

NCT NCT03567408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03567408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention (PCI)
Lead sponsor
Qian Gong
Phase
Phase 2
Overall status
Unknown status
Start date
September 15, 2018
Completion date
August 12, 2020
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease